Skip to search formSkip to main contentSkip to account menu

Antibody-drug Conjugate PF-06647020

Known as: ADC PF-06647020, PF-06647020 
An antibody-drug conjugate (ADC) composed of a proprietary monoclonal antibody against an unnamed tumor-associated antigen (TAA) linked to an as of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Background: PF-06647020, an ADC comprising a humanized monoclonal antibody against PTK7, a cleavable valine-citrulline linker… 
2018
2018
5565Background: PF-7020 is an ADC comprising of a humanized monoclonal antibody against PTK7, a cleavable valine-citrulline… 
2018
2018
2574Background: PF-7020, an ADC composed of humanized monoclonal antibody (Ab) against PTK7, auristatin payload, and valine… 
Review
2017
Review
2017
  • M. Katoh
  • International journal of oncology
  • 2017
  • Corpus ID: 6886218
Cancer stem cells (CSCs), which have the potential for self-renewal, differentiation and de-differentiation, undergo epigenetic…